Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate.

Wei XiangYongbo PengHongliang ZengChunping YuQun ZhangBiao LiuJiahao LiuXing HuWensu WeiMinhua DengNing WangXuewen LiuJianfei XieWeibin HouJin TangZhi LongLong WangJianye Liu

Published in: Biomaterials research (2022)

These results demonstrated that PTK7-GEMs is a successful targeted aptamer-drug conjugates strategy (APDCs) to treat BC, which will provide new directions for the precision treatment of BC in the field of biomarker-oriented tumor targeted therapy.

Keyphrases

cancer therapy
gold nanoparticles
sensitive detection
squamous cell carcinoma
emergency department
radiation therapy
locally advanced
label free
rectal cancer